Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Inheritance of the ε4 allele of ApoE is the only confirmed and consistently replicated risk factor for late onset AD. ApoE is also a key ligand for LRP, a major neuronal LDL receptor. Despite the considerable converging evidence that implicates ApoE and LRP in the pathogenesis of AD, the precise mechanism by which ApoE and LRP modulate the risk for AD remains elusive. Moreover, studies investigating expression of ApoE and LRP in AD brain have reported variable and contradictory results. To overcome these inconsistencies, we studied the mRNA expression of ApoE and LRP in the postmortem brain of persons who died at different stages of dementia and AD-associated neuropathology relative to controls by qPCR and Western blotting. Clinical dementia rating scores were used as a measure of dementia severity, whereas, Braak neuropathological staging and neuritic plaque density were used as indices of the neuropathological progression of AD. ApoE and LRP mRNA expression was significantly elevated in the postmortem inferior temporal gyrus (area 20) and the hippocampus from individuals with dementia compared to those with intact cognition. In addition to their strong association with the progression of cognitive dysfunction, LRP and ApoE mRNA levels were also positively correlated with increasing neuropathological hallmarks of AD. Additionally, Western blot analysis of ApoE protein expression in the hippocampus showed that the differential expression observed at the transcriptional level is also reflected at the protein level. Given the critical role played by LRP and ApoE in Aβ and cholesterol trafficking, increased expression of LRP and ApoE may not only disrupt cholesterol homeostasis but may also contribute to some of the neurobiological features of AD, including plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942 · cited 1×
“Recent evidence suggests that a large portion of intracellular A accumulates because of the interaction between A , ApoE, and LRP LaFerla et al., 2007).”
BackgroundProtective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“ApoE 4 is also associated with an earlier age of AD onset (GomezIsla et al., 1996; Roses, 1996) relative to persons with the 2/ 3 genotype (Corder et al., 1993, 1994).”
BackgroundCNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · cited 1×
“…carrier protein and after binding to LDL receptor family members on neuronal cell surfaces, lipidated ApoE facilitates synaptogenesis and modulates neurite outgrowth in an isoform-specific manner, with 4 inhibiting and 3 stimulating neurite outgrowth (Mauch et al., 2001; Nathan et al., 1994).”
BackgroundMutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“In particular, LRP-mediated ransport of A /ApoE complex across the blood-brain barrier (BBB) is a major pathway of A clearance from the brain to the periphery (Shibata et al., 2000; Tanzi et al., 2004).”
BackgroundStrittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294 · cited 2×
“Specifically, intraneuronal accumulation is believed to be toxic (Billings et al., 2005) and to contribute to early cognitive deficits in transgenic AD mouse model (Oddo et al., 2003; Zerbinatti et al., 2004).”
BackgroundIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“The accumulation of A inside neurons has also been observed in both AD patients and mice with brain amyloid deposition (Chui et al., 1999; Gouras et al., 2000; Mochizuki et al., 2000; Oddo et al., 2003; Shie et p n b A a a c f a A s c a a n l p g r D a A A R al., 2003).”
BackgroundSelf-citationLack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795 · cited 1×
“…carrier protein and after binding to LDL receptor family members on neuronal cell surfaces, lipidated ApoE facilitates synaptogenesis and modulates neurite outgrowth in an isoform-specific manner, with 4 inhibiting and 3 stimulating neurite outgrowth (Mauch et al., 2001; Nathan et al., 1994).”
BackgroundapoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 1×
“…with A with significantly higher affinity than lipid-poor ApoE (LaDu et l., 1995; Strittmatter et al., 1993b; Tokuda et al., 2000). ccumulating recent evidence suggests that lipidation of poE strongly disrupts A clearance across the blood-brain arrier (Bell et al., 2007; Deane et al., 2008).”
BackgroundAPOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · cited 2×
“ApoE 4 is also associated with an earlier age of AD onset (GomezIsla et al., 1996; Roses, 1996) relative to persons with the 2/ 3 genotype (Corder et al., 1993, 1994).”
BackgroundInfluentialAstrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · cited 1×
“In the brain, ApoE is predominantly synthesized by astrocytes and to some extent by microglia (Grehan et al., 2001; Pitas et al., 1987) while neurons preferentially express the receptors for ApoE, the low-density lipoprotein (LDL) receptor family (Beffert et al., 2004).”
BackgroundBell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670 · cited 1×
“…with A with significantly higher affinity than lipid-poor ApoE (LaDu et l., 1995; Strittmatter et al., 1993b; Tokuda et al., 2000). ccumulating recent evidence suggests that lipidation of poE strongly disrupts A clearance across the blood-brain arrier (Bell et al., 2007; Deane et al., 2008).”
BackgroundBerg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · cited 2×
“Hippocampus shows most severe and early pathogenic changes during the course of AD (Berg et al., 1998; Braak and Braak, 1991; Giannakopoulos et al., 1995; Mitchell et al., 2002).”
BackgroundIsoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537 · cited 1×
“Furthermore, mild to moderate cognitive deficits identified by the CDR scale represent some of the earliest manifestations of the disease process (Bennett et al., 2005; Morris et al., 2001) and this is borne out in our data.”
BackgroundChételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526 · cited 1×
“Moreover, longitudinal studies examining rate of atrophy in individuals with mild cognitive impairment who progressed to AD have consistently found atrophy in the inferior temporal gyrus (Chételat et al., 2005; Desikan et al., 2008; McDonald et al., 2009).”
BackgroundRAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · cited 1×
“As mentioned earlier, several studies have addressed the expression of LRP protein in AD brain albeit with conflicting results (Causevic et al., 2003; Donahue et al., 2006; Kang et al., 2000; Matsui et al., 2007; Qiu et al., 2001).”
ResultApoE-4 and Age at Onset of Alzheimer's Disease: The NIMH Genetics Initiative
Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C. P., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., et al. (1997) · Neurology · doi:10.1212/wnl.48.1.139 · Cited by 479 · cited 1×
“The effects of 4 allele on AD risk are maximal beween 60 and 70 years of age (Blacker et al., 1997).”
BackgroundApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459 · cited 1×
“These obserations suggest that increased lipidation of ApoE-A comlex may reduce the fraction of A that is cleared via LRP. Concomitant retention of ApoE-A complexes in the brain s likely to exacerbate the extracellular A load (DeMattos et al., 2004; Fryer et al., 2005).”
Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378
Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364 · cited 1×
“The accumulation of A inside neurons has also been observed in both AD patients and mice with brain amyloid deposition (Chui et al., 1999; Gouras et al., 2000; Mochizuki et al., 2000; Oddo et al., 2003; Shie et p n b A a a c f a A s c a a n l p g r D a A A R al., 2003).”
BackgroundKang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354
Holtzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease
McDonald, C. R., McEvoy, L. K., Gharapetian, L., Fennema-Notestine, C., Hagler, D. J., Holland, D., Koyama, A., Brewer, J. B., & Dale, A. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b16431 · Cited by 299
Haroutunian, V. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1185 · Cited by 289
Self-citationFryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278 · cited 1×
“These obserations suggest that increased lipidation of ApoE-A comlex may reduce the fraction of A that is cleared via LRP. Concomitant retention of ApoE-A complexes in the brain s likely to exacerbate the extracellular A load (DeMattos et al., 2004; Fryer et al., 2005).”
BackgroundTOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272
Ulery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., & Strickland, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7410 · Cited by 271
Bertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210 · cited 1×
“…of ApoE levels in cerebrospinal fluid (Landén et al., 1996; Lefranc et al., 1996; Sihlbom et al., 2008) and brain parenchyma (Beffert et al., 1999; Bertrand et al., 1995; Bray et al., 2004; Harr et al., 1996; Hesse et al., 1999; Lambert et al., 1997; Pirttila et al., 1996a, 1996b) of individuals…”
BackgroundNeurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease
Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L., & Mohs, R. C. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.713 · Cited by 201 · cited 1×
“Their cognitive status during the 6 months proximal to death was used to define the absence, presence, and extent of dementia at the time of death, as previously described (Davis et al., 1999; Haroutunian et al., 1998, 1999).”
MethodSelf-citationPietrzik, C. U., Busse, T., Merriam, D. E., Weggen, S., & Koo, E. H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf568 · Cited by 198 · cited 1×
“Furthermore, it has been shown that LRP facilitates APP endocytic trafficking and amyloidogenic processing by bringing both APP and -secrease into close proximity (Pietrzik et al., 2002; Ulery et al., 000).”
BackgroundPurification of Apolipoprotein E Attenuates Isoform-specific Binding to β-Amyloid
LaDu, M. J., Pederson, T. M., Frail, D. E., Reardon, C. A., Getz, G. S., & Falduto, M. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9039 · Cited by 189
Purohit, D. P., Perl, D. P., Haroutunian, V., Powchik, P., Davidson, M., & Davis, K. L. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.205 · Cited by 185 · cited 1×
“…neuropsychological examination and caregiver interview, showed no evidence of neurological or neuropsychiatric diseases, died of natural causes (myocardial infarction, various nonbrain nonhepatic cancers, and congestive heart failure) and had no discernable neuropathology (Purohit et al., 1998).”
BackgroundSelf-citationBeffert, U., Cohn, J. S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J., & Poirier, J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01894-6 · Cited by 142 · cited 2×
“Previous studies of ApoE levels in cerebrospinal fluid (Landén et al., 1996; Lefranc et al., 1996; Sihlbom et al., 2008) and brain parenchyma (Beffert et al., 1999; Bertrand et al., 1995; Bray et al., 2004; Harr et al., 1996; Hesse et al., 1999; Lambert et al., 1997; Pirttila et al., 1996a, 1996b)…”
BackgroundGrehan, S., Tse, E., & Taylor, J. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00812.2001 · Cited by 138 · cited 1×
“In the brain, ApoE is predominantly synthesized by astrocytes and to some extent by microglia (Grehan et al., 2001; Pitas et al., 1987) while neurons preferentially express the receptors for ApoE, the low-density lipoprotein (LDL) receptor family (Beffert et al., 2004).”
BackgroundZerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M., & Bu, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305803101 · Cited by 133 · cited 1×
“Specifically, intraneuronal accumulation is believed to be toxic (Billings et al., 2005) and to contribute to early cognitive deficits in transgenic AD mouse model (Oddo et al., 2003; Zerbinatti et al., 2004).”
BackgroundZerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., Holtzman, D. M., & Bu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604436200 · Cited by 129 · cited 1×
“It has been shown that a fraction of A that is internalized by neurons can lead to ntraneuronal A accumulation (Zerbinatti et al., 2006) which is toxic (Billings et al., 2005).”
BackgroundApolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo
Rensen, P. C. N., Jong, M. C., van Vark, L. C., van der Boom, H., Hendriks, W. L., van Berkel, T. J. C., Biessen, E. A. L., & Havekes, L. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8564 · Cited by 86 · cited 1×
“Following receptor-mediated endocytosis, ApoE may be either degraded or recycled back to the cell surface (Rensen et al., 2000).”
BackgroundInfluentialTau protein abnormalities associated with the progression of alzheimer disease type dementia
Haroutunian, V., Davies, P., Vianna, C., Buxbaum, J. D., & Purohit, D. P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.001 · Cited by 86
Self-citationAβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease
Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y., & Shoji, S. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04937-5 · Cited by 85 · cited 1×
“The accumulation of A inside neurons has also been observed in both AD patients and mice with brain amyloid deposition (Chui et al., 1999; Gouras et al., 2000; Mochizuki et al., 2000; Oddo et al., 2003; Shie et p n b A a a c f a A s c a a n l p g r D a A A R al., 2003).”
BackgroundIshii, K., Tamaoka, A., Mizusawa, H., Shoji, S.-I., Ohtake, T., Fraser, P. E., Takahashi, H., Tsuji, S., Gearing, M., Mizutani, T., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01363-7 · Cited by 85 · cited 1×
“Interestingly, results of studies of ApoE messenger RNA (mRNA) levels have been more consistent and have shown ApoE mRNA levels to be elevated in AD brain (Ishii et al., 1997; Wolf et al., 1998; Zarow and Victoroff, 1998).”
BackgroundModulation of Aβ Deposition in APP Transgenic Mice by an Apolipoprotein E Null Background
IRIZARRY, M. C., REBECK, G. W., CHEUNG, B., BALES, K., PAUL, S. M., HOLZMAN, D., & HYMAN, B. T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06919.x · Cited by 66 · cited 1×
“…transgenic mice with onsiderable amyloid deposits, when crossed onto a mouse ith an ApoE knockout background, showed a significant ecrease in A deposits and an almost complete lack of true myloid plaques and neuritic dystrophy (Bales et al., 1997; oltzman et al., 1999, 2000; Irizarry et al., 2000).”
BackgroundAkram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.006 · Cited by 50 · cited 3×
“VCP, a 97-kDa rotein, has been previously validated as reliable internal tandard (Akram et al., 2010; Bauer et al., 2009).”
BackgroundMethodSelf-citationLefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H., & Delacourte, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12774-9 · Cited by 47 · cited 1×
“Previous studies of ApoE levels in cerebrospinal fluid (Landén et al., 1996; Lefranc et al., 1996; Sihlbom et al., 2008) and brain parenchyma (Beffert et al., 1999; Bertrand et al., 1995; Bray et al., 2004; Harr et al., 1996; Hesse et al., 1999; Lambert et al., 1997; Pirttila et al., 1996a, 1996b)…”
BackgroundAllelic expression of APOE in human brain: Effects of epsilon status and promoter haplotypes
Bray, N. J., Jehu, L., Moskvina, V., Buxbaum, J. D., Dracheva, S., Haroutunian, V., Williams, J., Buckland, P. R., Owen, M. J., & O'Donovan, M. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh299 · Cited by 45 · cited 1×
“…fluid (Landén et al., 1996; Lefranc et al., 1996; Sihlbom et al., 2008) and brain parenchyma (Beffert et al., 1999; Bertrand et al., 1995; Bray et al., 2004; Harr et al., 1996; Hesse et al., 1999; Lambert et al., 1997; Pirttila et al., 1996a, 1996b) of individuals with AD have yielded…”
BackgroundSelf-citationApolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls
Pirttilä, T., Soininen, H., Heinonen, O., Lehtimäki, T., Bogdanovic, N., Paljärvi, L., Kosunen, O., Winblad, B., Riekkinen, P., Wisniewski, H. M., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00183-7 · Cited by 42
Cited by
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
“viduals (50, 51) although there is a conflicting report”
BackgroundWatson, C. T., Roussos, P., Garg, P., Ho, D. J., Azam, N., Katsel, P. L., Haroutunian, V., & Sharp, A. J. (2016) · Genome Medicine · doi:10.1186/s13073-015-0258-8 · Cited by 201
“…both relevant to known molecular and neurological impairments in AD, and consistent with findings from AD transcriptome studies and GWAS [83 – 86 We also found that DMRs were distributed non-randomly in the genome, with biases in their co-localization within gene and CpG island annotations,…”
Self-citationZhang, Q., Ma, C., Gearing, M., Wang, P. G., Chin, L.-S., & Li, L. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0524-2 · Cited by 165
“Each experiment was repeated three times with similar results DJ-1, APOE, clusterin (CLU), and UCH-L1 [1, 17, 19, 55].”
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
Li, Y., Macyczko, J. R., Liu, C.-C., & Bu, G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.011 · Cited by 61
Gamache, J., Gingerich, D., Shwab, E. K., Barrera, J., Garrett, M. E., Hume, C., Crawford, G. E., Ashley-Koch, A. E., & Chiba-Falek, O. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01120-5 · Cited by 20
“Foremost, previously we found significantly higher levels of APOE -mRNA in brain tissues obtained from e3/3 LOAD patients compared to e3/3 healthy donors, consistent with other reports showing elevated levels of APOE -mRNA in LOAD brains [21–23 , 100].”
Result
Metadata
- Authors
- Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 33
- Issue
- 3
- Pages
- 628.e1-628.e14
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2009162143
- Cited by
- 38
- References
- 50
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.